Rating History for Celldex Therapeutics (CLDX) by Barclays

More Stocks Rated by Barclays | Latest Ratings for CLDX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/8/2026 Etzer Darout Maintain Overweight
(N/A)		 48.00
(45.00)		  
 		   Details